(99) suggested that the higher the expression of CD147 or the better the degree of tumor differentiation, the longer the survival of patients with liver cancer, thus an effective therapeutic target for interfering with or reversing HCC progression. This evidence concerns the gene BSG and hepatocellular carcinoma.